Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
Authors
Keywords
-
Journal
Medicina-Lithuania
Volume 55, Issue 2, Pages 42
Publisher
MDPI AG
Online
2019-02-11
DOI
10.3390/medicina55020042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signaling pathways as therapeutic targets in biliary tract cancer
- (2017) Jennifer Yang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of the Notch signaling in cholangiocarcinoma
- (2017) Antonio Cigliano et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
- (2017) Philip Morgan et al. PHARMACOECONOMICS
- Update on cholangiocarcinoma: potential impact of genomic studies on clinical management
- (2017) Dirk Walter et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Intrahepatic cholangiocarcinoma: current management and emerging therapies
- (2017) Amir A. Rahnemai-Azar et al. Expert Review of Gastroenterology & Hepatology
- Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets
- (2017) Douglas V.N.P. Oliveira et al. Expert Review of Gastroenterology & Hepatology
- Analysis of origin and protein-protein interaction maps suggests distinct oncogenic role of nuclear EGFR during cancer evolution
- (2017) Ainur Sharip et al. Journal of Cancer
- Cholangiocarcinoma — Current Treatment Options
- (2017) S. Friman Scandinavian Journal of Surgery
- A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
- (2016) Sumera Rizvi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
- (2016) Grazia Palomba et al. Journal of Translational Medicine
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
- (2016) Kulthida Vaeteewoottacharn et al. TUMOR BIOLOGY
- Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma
- (2015) Finn Ole Larsen et al. ACTA ONCOLOGICA
- Epidemiology of cholangiocarcinoma
- (2015) Annika Bergquist et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-typeKRASadvanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
- (2015) Francesco Leone et al. CANCER
- Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
- (2015) A. Moeini et al. CLINICAL CANCER RESEARCH
- 2382 A proof-of-concept study of MEK inhibitor trametinib monotherapy in patients with biliary tract cancers
- (2015) T. Ioka et al. EUROPEAN JOURNAL OF CANCER
- Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma
- (2015) Takuji Okusaka et al. HEPATOLOGY RESEARCH
- Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
- (2015) Elizabeth R. Kessler et al. INVESTIGATIONAL NEW DRUGS
- A phase I trial of mFOLFOX6 combined with the oral PI3K inhibitor BKM120 in patients with advanced refractory solid tumors
- (2015) Autumn J. McRee et al. INVESTIGATIONAL NEW DRUGS
- A phase II trial of cabozantinib (XL-184) in patients with advanced cholangiocarcinoma.
- (2015) Lipika Goyal et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2/neu-directed therapy for biliary tract cancer
- (2015) Milind Javle et al. Journal of Hematology & Oncology
- PI3King the Lock
- (2015) David King et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
- (2015) Juan W Valle et al. LANCET ONCOLOGY
- Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma
- (2015) PANAGIOTIS PALIOGIANNIS et al. Molecular Medicine Reports
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
- (2015) Jean-Florian Guion-Dusserre et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
- (2015) Giuseppe Palmieri et al. Frontiers in Oncology
- A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
- (2014) S. Pant et al. ANNALS OF ONCOLOGY
- A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
- (2014) A. Santoro et al. ANNALS OF ONCOLOGY
- S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
- (2014) A B El-Khoueiry et al. BRITISH JOURNAL OF CANCER
- Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
- (2014) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
- (2014) Dorothee Riedlinger et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
- (2014) Sumera Rizvi et al. SEMINARS IN LIVER DISEASE
- A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
- (2013) J K Lee et al. BRITISH JOURNAL OF CANCER
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting
- (2013) Alphonse E. Sirica et al. HEPATOLOGY
- Notch signaling and new therapeutic options in liver disease
- (2013) Carola Maria Morell et al. JOURNAL OF HEPATOLOGY
- Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma
- (2013) Nataliya Razumilava et al. JOURNAL OF HEPATOLOGY
- Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
- (2013) D Sia et al. ONCOGENE
- Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
- (2013) Hong Ling et al. PLoS One
- Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
- (2013) A. A. Belov et al. Cold Spring Harbor Perspectives in Biology
- Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer
- (2012) L. H. Jensen et al. ANNALS OF ONCOLOGY
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- Identifying and Targeting ROS1 Gene Fusions in Non-Small Cell Lung Cancer
- (2012) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
- (2012) Shahid A Khan et al. GUT
- Inhibition of hedgehog signaling attenuates carcinogenesisin vitroand increases necrosis of cholangiocellular carcinoma
- (2012) Mona El Khatib et al. HEPATOLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
- (2012) Sayaka Sekiya et al. JOURNAL OF CLINICAL INVESTIGATION
- HER2/neu May Not Be an Interesting Target in Biliary Cancers: Results of an Early Phase II Study with Lapatinib
- (2012) Joshua Peck et al. ONCOLOGY
- Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma
- (2012) Sirintip Boonjaraspinyo et al. TUMOR BIOLOGY
- Desmoplasia: A Response or a Niche?
- (2012) Yves A. DeClerck Cancer Discovery
- Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
- (2011) M Miyamoto et al. BRITISH JOURNAL OF CANCER
- SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
- (2011) Anthony B. El-Khoueiry et al. INVESTIGATIONAL NEW DRUGS
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Cholangiocarcinoma—controversies and challenges
- (2011) Tushar Patel Nature Reviews Gastroenterology & Hepatology
- Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment
- (2010) Somchai Pinlaor et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy
- (2010) Zichen Zhang et al. HEPATOLOGY
- Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
- (2010) Sam J. Lubner et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
- (2010) Birgit Gruenberger et al. LANCET ONCOLOGY
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
- (2009) C Bengala et al. BRITISH JOURNAL OF CANCER
- A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
- (2009) Ramesh K. Ramanathan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
- (2009) James E. Everhart et al. GASTROENTEROLOGY
- Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas
- (2009) Nathalie Guedj et al. JOURNAL OF HEPATOLOGY
- Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion
- (2009) Yufu Ye et al. JOURNAL OF SURGICAL ONCOLOGY
- Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
- (2009) Andrew X Zhu et al. LANCET ONCOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Cholangiocarcinoma
- (2008) Stefania Mosconi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
- Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
- (2008) Alphonse E Sirica WORLD JOURNAL OF GASTROENTEROLOGY
- Cholangiocarcinoma: A compact review of the literature
- (2008) Yucel Ustundag et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search